HIV-1 restriction by SERINC5

被引:6
|
作者
Cano-Ortiz, Lucia [1 ,2 ]
Luedde, Tom [1 ]
Muenk, Carsten [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Bldg 23-12-U1-82,Moorenstr 5, D-40225 Dusseldorf, Germany
[2] Univ Fed Rio Grande, Inst Ciencias Basicas Saude, Dept Microbiol, Lab Virol, Porto Alegre, RS, Brazil
关键词
SERINC5; Nef; HIV-1; Restriction factors; HUMAN-IMMUNODEFICIENCY-VIRUS; PRIMATE LENTIVIRUSES; INFECTIVITY FACTOR; GLYCOSYLATED-GAG; PROTEIN FAMILY; PORE FORMATION; NEF; REPLICATION; ANTAGONISM; FUSION;
D O I
10.1007/s00430-022-00732-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Delta Nef). SER5 incorporated into the viral membrane impairs the entry of HIV-1 by disrupting the fusion between the viral and the plasma membrane after envelope receptor interaction induced the first steps of the fusion process. The mechanisms of how SER5 prevents membrane fusion are not fully understood and viral envelope proteins were identified that escape the SER5-mediated restriction. Primate lentiviruses, such as HIV-1 and simian immunodeficiency viruses (SIVs), use their accessory protein Nef to downregulate SER5 from the plasma membrane by inducing an endocytic pathway. In addition to being directly antiviral, recent data suggest that SER5 is an important adapter protein in innate signaling pathways leading to the induction of inflammatory cytokines. This review discusses the current knowledge about HIV-1 restriction by SER5.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 50 条
  • [31] Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection
    Beitari, Saina
    Pan, Qinghua
    Finzi, Andres
    Liang, Chen
    JOURNAL OF VIROLOGY, 2020, 94 (16)
  • [32] SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env
    Kirschman, Junghwa
    Marin, Mariana
    Chen, Yen-Cheng
    Chen, Junhua
    Herschhorn, Alon
    Smith, Amos B., III
    Melikyan, Gregory B.
    VIRUSES-BASEL, 2022, 14 (07):
  • [33] SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation
    Zutz, Ariane
    Schoelz, Christian
    Schneider, Stephanie
    Pierini, Virginia
    Muenchhoff, Maximilian
    Sutter, Kathrin
    Wittmann, Georg
    Dittmer, Ulf
    Draenert, Rika
    Bogner, Johannes R.
    Fackler, Oliver T.
    Keppler, Oliver T.
    JOURNAL OF INNATE IMMUNITY, 2020, 12 (05) : 399 - 409
  • [34] Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3-and SERINC5-Mediated HIV-1 Restriction
    Kruize, Zita
    van Nuenen, Ad C.
    van Wijk, Stan W.
    Girigorie, Arginell F.
    van Dort, Karel A.
    Booiman, Thijs
    Kootstra, Neeltje A.
    VIRUSES-BASEL, 2021, 13 (03):
  • [35] The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles
    Trautz, Birthe
    Wiedemann, Hannah
    Luechtenborg, Christian
    Pierini, Virginia
    Kranich, Jan
    Glass, Barbel
    Kreausslich, Hans-Georg
    Brocker, Thomas
    Pizzato, Massimo
    Ruggieri, Alessia
    Bruegger, Britta
    Fackler, Oliver T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (33) : 13702 - 13713
  • [36] Characterisation and functional analysis of the novel restriction factor Serinc5
    Schulte, Bianca
    Opp, Silvana
    Diaz-Griffero, Felipe
    RETROVIROLOGY, 2016, 13
  • [37] Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
    Jin, Steven W.
    Mwimanzi, Francis M.
    Mann, Jaclyn K.
    Bwana, Mwebesa Bosco
    Lee, Guinevere Q.
    Brumme, Chanson J.
    Hunt, Peter W.
    Martin, Jeff N.
    Bangsberg, David R.
    Ndung'u, Thumbi
    Brumme, Zabrina L.
    Brockman, Mark A.
    PLOS PATHOGENS, 2020, 16 (09)
  • [38] SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins
    Sood, Chetan
    Marin, Mariana
    Chande, Ajit
    Pizzato, Massimo
    Melikyan, Gregory B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (14) : 6014 - 6026
  • [39] 3D Superresolution Studies of the Effect of SERINC5 on Env Glycoprotein Distribution on HIV-1 Particles
    Chen, Yen-Cheng
    Sood, Chetan
    Marin, Mariana
    Aaron, Jesse
    Chew, Teng-Leong
    Salaita, Khalid
    Melikyan, Gregory B.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 151A - 151A
  • [40] Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction
    Zhang, Xianfeng
    Zhou, Tao
    Yang, Jie
    Lin, Yumei
    Shi, Jing
    Zhang, Xihe
    Frabutt, Dylan A.
    Zeng, Xiangwei
    Li, Sunan
    Venta, Patrick J.
    Zheng, Yong-Hui
    JOURNAL OF VIROLOGY, 2017, 91 (10)